Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.
Protein kinase C gamma (PKCγ) as a novel marker to assess the functional status of the corticospinal tract in experimental autoimmune encephalomyelitis (EAE).
Cesarean delivery may increase the risk of multiple sclerosis.
Central motor conduction time.
[Cavitary lesions in multiple sclerosis: Multicenter study on twenty patients.]
Activation of MSRV-Type Endogenous Retroviruses during Infectious Mononucleosis and Epstein-Barr Virus Latency: The Missing Link with Multiple Sclerosis?
Disturbed function of the blood-cerebrospinal fluid barrier aggravates neuro-inflammation.
Preclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug.
Onset-adjusted incidence of multiple sclerosis in the Girona province (Spain): Evidence of increasing risk in the south of Europe.
MS arising during Tocilizumab therapy for rheumatoid arthritis.
Four Hours is Enough for Lactation Interruption After High-Dose Methylprednisolone Treatment in Multiple Sclerosis Mothers by Measuring Milk Cortisol Levels.
Integrated sphingosine-1 phosphate signaling in the central nervous system: From physiological equilibrium to pathological damage.
The influence of vitamin D on postpartum relapse and quality of life in pregnant multiple sclerosis patients.
Activation Status of Human Microglia Is Dependent on Lesion Formation Stage and Remyelination in Multiple Sclerosis.
The Neurocognitive Profile of the Cerebellum in Multiple Sclerosis.
Multiple sclerosis relapse mimicking a transient ischemic attack.
The relationship of age with the clinical phenotype in multiple sclerosis.
[Capabilities of positron emission tomography to study mecha-nisms of multiple sclerosis: own data and literature].
The killer immunoglobulin-like receptor KIR3DL1 in combination with HLA-Bw4 is protective against multiple sclerosis in African Americans.
Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations.
Relevance of quality of life assessment for multiple sclerosis patients with memory impairment.
Axonal expression of sodium channels and neuropathology of the plaques in multiple sclerosis.
The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine CNS diseases.
Overview of magnetic resonance imaging for management of relapsing-remitting multiple sclerosis in everyday practice.
Clinical and Radiological Characterization of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients: A Retrospective Analysis and Review of the Literature.
Pages
« first
‹ previous
…
609
610
611
612
613
614
615
616
617
…
next ›
last »